Table 2.

Differences in neoplasm related deaths for Sarcoidosis patients and the general Spanish population for the period 2016–2019.

	Neoplasm-related deaths N (%)			Mean age (years), (SD)
	Non-sarcoidosis	Sarcoidosis	p	Non-sarcoidosis	Sarcoidosis	p
Total	139,453	77	–	70.7 (13.5)	67.4 (13.3)	0.034
SON	127,093 (91.1)	60 (78.9)	0.001	70.6 (13.3)	68.8 (13.5)	0.296
HN	12,360 (8.9)	16 (20.7)	0.001	71.9 (15.5)	63.6 (12.5)	0.032
Malign neoplasm	136,807 (98.1)	73 (96.1)	0.176	70.6 (13.5)	67.6 (13.6)	0.064
Malign SON	124,843 (89.5)	59 (77.6)	0.002	70.5 (13.3)	68.9 (13.6)	0.375
Malign HN	11,989 (8.6)	14 (17.9)	0.003	71.7 (15.6)	62.2 (12.8)	0.023
Benign SON	727 (0.5)	0	1	72.3 (13.5)	–	–
UB neoplasm	1695 (1.2)	3 (3.9)	0.066	78.7 (13.9)	68.3 (8.1)	0.196
UB SON	1326 (1)	1 (1.3)	0.516	78.6 (14.7)	59	0.182
UB HN	369 (0,3)	2 (2.6)	0.018	79 (10.6)	74 (2)	0.419
In situ carcinoma	187 (0.1)	0	1	73.4 (12.4)	–	–

SD: Standard deviation, SON: Solid organ neoplasm, HN: Haematological neoplasm, UB: Uncertain behaviour.

Values in bold highlight statistically significant difference.